@article{3033606,
    title = "Efficacy and tolerability of once-weekly selinexor, bortezomib, and
dexamethasone in comparison with standard twice-weekly bortezomib and
dexamethasone in previously treated multiple myeloma with renal
impairment: Subgroup analysis from the BOSTON study",
    author = "Delimpasi, Sosana and Mateos, Maria Victoria and Auner, Holger W. and and Gavriatopoulou, Maria and Dimopoulos, Meletios A. and Quach, Hang and and Pylypenko, Halyna and Hajek, Roman and Leleu, Xavier and Dolai, Tuphan and Kanti and Sinha, Dinesh Kumar and Venner, Christopher P. and Benjamin, and Reuben and Garg, Mamta Krishnan and Doronin, Vadim and Levy, Yair and and Moreau, Philippe and Chai, Yi and Arazy, Melina and Shah, Jatin and and Shacham, Sharon and Kauffman, Michael G. and Richardson, Paul G. and and Grosicki, Sebastian",
    journal = "American Journal of Hematology",
    year = "2022",
    volume = "97",
    number = "3",
    pages = "E83-E86",
    publisher = "Wiley",
    issn = "0361-8609, 1096-8652",
    doi = "10.1002/ajh.26434"
}